Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Omeprazole therapy and salivary flow rate in duodenal ulcer patients.

Zbigniew Namiot, Jan Stasiewicz, Maciej Kralisz, Małgorzata Kozuszyńska-Topór, Adam R Markowski, Fouad K Aljanaby, Andrzej Kemona, Jan Górski

Med Sci Monit 2001; 7(2): CR276-281 :: ID: 421149

Abstract

BACKGROUND: Previous reports have shown that in some reflux-oesophagitispatients omeprazole therapy alters salivary secretion. The aim of the study was to examine this effectin duodenal ulcer patients.
MATERIAL AND METHODS: Thirty nine Helicobacter pylori positive subjects ofboth sexes, predominantly men, were recruited for the study. They were taking for two weeks only omeprazole(n = 17), or omeprazole in combination with either amoxycillin or amoxycillin and tinidazole (n = 22).Salivary secretion was assessed before and at the end of the treatment, both in basal conditions andduring a gastric secretory test. Gastric secretion was monitored concurrently with salivary flow rate.Additionally gastritis score and serum gastrin levels were assessed.
RESULTS: Basal salivary secretionsremained unchanged in patients on omeprazole monotherapy, but decreased in five of eight saliva collectionperiods in patients on eradication regimens. During the gastric secretory test, salivary secretions fellin both groups, but only after pentagastrin stimulation (in one collection period in patients on omeprazole,and in three collection periods in patients on eradication therapy). The observed changes in salivarysecretion were inversely related to the pre-treatment gastric pH values.
CONCLUSION: The influence ofomeprazole and omeprazole-based eradication therapies on salivary flow rate is presumably secondary tochanges in gastric pH values and is likely to be related to oesophago-salivary reflex generation.

Keywords: Duodenal Ulcer, Duodenal Ulcer, omeprazole, Salivation

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

07 May 2024 : Clinical Research  

Treatment of AVN-Induced Proximal Pole Scaphoid Nonunion Using a Fifth and Fourth Extensor Compartmental Ar...

Med Sci Monit In Press; DOI: 10.12659/MSM.944553  

16 Mar 2024 : Clinical Research  

Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Vario...

Med Sci Monit In Press; DOI: 10.12659/MSM.943228  

08 May 2024 : Clinical Research  

Effect of Individualized PEEP Guided by Driving Pressure on Diaphragm Function in Patients Undergoing Lapar...

Med Sci Monit In Press; DOI: 10.12659/MSM.944022  

21 Mar 2024 : Clinical Research  

Impact of Serum Vitamin D, B6, and B12 and Cognitive Functions on Quality of Life in Peri- and Postmenopaus...

Med Sci Monit In Press; DOI: 10.12659/MSM.943249  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750